Healthcare workers in protective gear manage patient isolation areas inside treatment facilities. In response to the geographical spread, authorities adopted a decentralized treatment approach to establish healthcare facilities closer to rural communities affected by the outbreak. Nearly 1,400 treatment beds have been set up across 59 specialized operational centers by response teams. However, assessments indicate that an additional 1,600 beds are needed to reach the targeted capacity of 3,000 beds. Achieving this expansion will require recruiting and training about 5,000 more healthcare professionals to support the current 9,000 health workers necessary for full operational readiness. Limited operational funds and resource constraints have further hindered efforts to expand field operations in remote provinces. On average, daily needs for personal protective equipment are $25 per healthcare worker entering high-risk patient isolation zones. Running a standard 50-bed treatment facility demands around $500,000, posing significant financial difficulties amid decreasing global donor funding. Data shared via the Emirates News Agency highlights that fully operational treatment centers and adequately trained personnel remain essential for improving patient survival and halting virus transmission. Staffing Shortages and Funding Challenges Slow Ebola Response in Congolese Provinces One of the main structural obstacles is the ongoing shortage of non-governmental partners capable of managing complex isolation facilities. Luca Fontana, the WHO technical lead, pointed out that only five or six global humanitarian organizations possess the expertise required to establish and operate specialized Ebola treatment centers. Without additional operational partners to take over existing sites, technical teams remain tied to

Congo’s Ebola response expands as Bundibugyo transmission remains active. This outbreak has become both Congo’s largest and most lethal Ebola episode on record. It also ranks as the second-largest Ebola outbreak worldwide, following the 2014-2016 epidemic in West Africa. Ituri remains at the epicenter of the crisis, accounting for roughly 85% of cases and 88% of deaths. Tedros highlighted that many deaths involve individuals not registered as known contacts, indicating ongoing gaps in identifying transmission chains. Challenges such as community deaths and unsafe burials continue to hinder containment efforts. According to Africa CDC, over 60% of fatalities during the most recent seven-day period occurred in community settings. Health authorities have also reported delays in early detection and in transporting patients to treatment centers. Recent government data shows 1,439 recoveries and a case fatality rate of 48.6%, underscoring the severity of the Bundibugyo strain. Ongoing transmission in eastern Congo Even though recent weeks have seen some signs of case decline, transmission persists in 51 health zones. Four zones have not reported new cases for over 42 days and have halted transmission. Additionally, five zones have experienced between 21 and 42 days without new infections. Officials have warned that this decrease is too recent to confirm that the Ebola outbreak nationwide is under control. To combat the outbreak, the WHO has ramped up testing, treatment, and field operations in affected regions. Over 330 tonnes of

In Kisangani, the capital of Tshopo Province, health authorities in the Democratic Republic of the Congo have launched a targeted Ebola immunization campaign to stem the deadliest outbreak in the country’s history. Frontline healthcare workers, emergency response teams, and individuals with direct contact to confirmed cases are being prioritized during the initial deployment phase. Health Minister Roger Kamba confirmed that the government has begun using doses of the Ervebo vaccine to protect front-line personnel working in the affected eastern regions.

EU diagnostic support expands as health authorities respond to the Bundibugyo Ebola outbreak. The PCR testing kits will be delivered to the World Health Organization’s Hub for Global Health Emergencies Logistics based in Dubai. WHO will oversee their distribution to regions involved in the Ebola response. PCR diagnostics are vital for confirming infections, as laboratories can process numerous samples efficiently and with high precision. Furthermore, the equipment is compatible with existing laboratory infrastructure. Rapid confirmation of cases allows health teams to identify infected individuals, organize appropriate treatment and isolation, and facilitate contact tracing efforts around confirmed cases.

DR Congo expands its Ebola response as Bundibugyo cases spread across six provinces. Following the government’s request from the global Ebola stockpile, the International Coordinating Group on Vaccine Provision approved the release of these doses. WHO indicated that 20,000 doses will support a Phase 3 clinical trial targeting Bundibugyo virus disease. The remaining 50,000 doses are designated for frontline and healthcare workers in line with current vaccination guidelines. This allocation was announced on Aug. 20, and both WHO and Africa CDC expressed support for it. Ervebo holds approval for Ebola outbreaks caused by the Ebola virus, formerly known as Zaire ebolavirus, but it does not have specific authorization for Bundibugyo virus disease. Laboratory and animal studies suggest the possibility of cross-protection, though the effectiveness in humans remains undetermined. The clinical trial aims to assess the vaccine’s impact during the ongoing outbreak and provide additional evidence for public health decision-making. WHO advises that recipients should be informed about known risks, potential benefits, and the current limitations of the vaccine.

Congo’s Ebola crisis can still be contained within three months if adequate resources are allocated to response teams. The most recent official data reports 5,021 confirmed cases and 2,378 fatalities as of Aug. 16. Currently, cases are distributed across 55 health zones in six provinces, with the case fatality ratio reaching 47.4%. This toll makes it the deadliest Ebola outbreak in the history of the country and the second-largest Ebola epidemic ever recorded worldwide.